Literature DB >> 19143004

Reduced testosterone levels in males with lone atrial fibrillation.

Jiangtao Lai1, Dongchen Zhou, Shudong Xia, Yunpeng Shang, Lihong Want, Liangrong Zheng, Jianhua Zhu.   

Abstract

BACKGROUND: Sex hormones play an important role in the development of cardiovascular disease. Testosterone and estradiol have been reported to be down-regulated in subjects with coronary artery disease and heart failure, but has not been studied in atrial fibrillation (AF). HYPOTHESIS: Levels of sex hormones may be associated with susceptibility to lone AF in men.
METHODS: Fifty-eight male subjects who had electrocardiographic evidence of paroxysmal or chronic AF and a structurally normal heart on echocardiography were enrolled. Subjects were excluded if they had been taking angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), or statins within 3 mo or had a history of coronary artery disease, rheumatic heart disease, cardiomyopathy, significant valvular disease, hyperthyroidism, or hypertension. Fifty-eight controls were recruited from a healthy outpatient population. Serum total testosterone and estradiol levels were determined using a commercially available radioimmunoassay.
RESULTS: Mean levels of testosterone were significantly lower in subjects with lone AF when compared with controls (476 ng/dl versus 514 ng/dl, p = 0.005). No significant differences were found in the estradiol levels between the 2 groups (31.9 pg/ml versus 32.4 pg/ml, p = 0.789).
CONCLUSION: Reduced testosterone levels may be associated with susceptibility to lone AF in men. Copyright (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143004      PMCID: PMC6652862          DOI: 10.1002/clc.20423

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  18 in total

1.  Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.

Authors:  Jared W Magnani; Carlee B Moser; Joanne M Murabito; Lisa M Sullivan; Na Wang; Patrick T Ellinor; Ramachandran S Vasan; Emelia J Benjamin; Andrea D Coviello
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-08

2.  Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study.

Authors:  Michael A Rosenberg; Molly M Shores; Alvin M Matsumoto; Petra Bůžková; Leslie A Lange; Richard A Kronmal; Susan R Heckbert; Kenneth J Mukamal
Journal:  Clin Cardiol       Date:  2018-06-08       Impact factor: 2.882

3.  Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.

Authors:  Li Yang; Qu Xiufen; Sun Shuqin; Yu Yang; Song Ying; Yu Yanwei; Feng Wei; Yin Dechun
Journal:  J Interv Card Electrophysiol       Date:  2011-05-19       Impact factor: 1.900

Review 4.  Relationships between endogenous and exogenous testosterone and cardiovascular disease in men.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Rev Endocr Metab Disord       Date:  2022-10-11       Impact factor: 9.306

5.  High serum testosterone levels are associated with excessive erythrocytosis of chronic mountain sickness in men.

Authors:  Gustavo F Gonzales; Manuel Gasco; Vilma Tapia; Cynthia Gonzales-Castañeda
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-24       Impact factor: 4.310

6.  Sex hormone levels and sexual dysfunction in men after coronary artery bypass graft.

Authors:  Seyed Khalil Forouzannia; Mohammad Hassan Abdollahi; Seyedhossein Hekmatimoghaddam; Sadegh Ali Hassan Sayegh
Journal:  Iran J Reprod Med       Date:  2012-09

Review 7.  Atrial Fibrillation and Its Association with Endocrine Disorders.

Authors:  Manjari Devidi; Avanija Buddam; Sunil Dacha; D Sudhaker Rao
Journal:  J Atr Fibrillation       Date:  2014-02-28

Review 8.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

9.  Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.

Authors:  Molly M Shores; Alice M Arnold; Mary L Biggs; W T Longstreth; Nicholas L Smith; Jorge R Kizer; Anne R Cappola; Calvin H Hirsch; Brett T Marck; Alvin M Matsumoto
Journal:  Clin Endocrinol (Oxf)       Date:  2014-05-05       Impact factor: 3.478

10.  Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Dylan Berger; Aaron R Folsom; Pamela J Schreiner; Lin Y Chen; Erin D Michos; Wesley T O'Neal; Elsayed Z Soliman; Alvaro Alonso
Journal:  Maturitas       Date:  2019-03-31       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.